CCL Products (India) Ltd Share Price – NSE  / BSE

Plantation & Plantation Products, Small Cap

Pfizer Ltd, Syngene International Ltd, Caplin Point Laboratories Ltd, Devyani International Ltd are among the other stocks to see a surge in volumes on NSE today, 08 June 2026.

CCL Products (India) Ltd recorded volume of 36.98 lakh shares by 14:14 IST on NSE, a 25.04 times surge over two-week average daily volume of 1.48 lakh shares. The stock gained 6.11% to Rs.1,145.00. Volumes stood at 1.47 lakh shares in the last session.

Pfizer Ltd witnessed volume of 1.84 lakh shares by 14:14 IST on NSE, a 10.43 times surge over two-week average daily volume of 17667 shares. The stock increased 1.56% to Rs.4,526.00. Volumes stood at 28646 shares in the last session.

Syngene International Ltd registered volume of 49.23 lakh shares by 14:14 IST on NSE, a 8.54 fold spurt over two-week average daily volume of 5.77 lakh shares. The stock rose 3.28% to Rs.448.50. Volumes stood at 2.89 lakh shares in the last session.

Caplin Point Laboratories Ltd saw volume of 5.15 lakh shares by 14:14 IST on NSE, a 5.42 fold spurt over two-week average daily volume of 94862 shares. The stock increased 4.52% to Rs.2,125.00. Volumes stood at 84426 shares in the last session.

Devyani International Ltd clocked volume of 45.46 lakh shares by 14:14 IST on NSE, a 5.06 times surge over two-week average daily volume of 8.98 lakh shares. The stock lost 1.31% to Rs.111.65. Volumes stood at 8.52 lakh shares in the last session.

Powered by Capital Market - Live News

CCL Products (India) has allotted 88,027 equity shares under ESOS on 04 June 2026. Post allotment, the paid up equity share capital has increased to Rs. 26,70,55,840/- divided into 13,35,27,920 of Rs. 2/- each.

CCL Products (India) announced that the Board of Directors of the Company at its meeting held on 7 May 2026, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 150%) , subject to the approval of the shareholders.

Net profit of CCL Products (India) rose 12.43% to Rs 114.53 crore in the quarter ended March 2026 as against Rs 101.87 crore during the previous quarter ended March 2025. Sales rose 46.49% to Rs 1224.44 crore in the quarter ended March 2026 as against Rs 835.85 crore during the previous quarter ended March 2025.

For the full year,net profit rose 25.06% to Rs 388.10 crore in the year ended March 2026 as against Rs 310.34 crore during the previous year ended March 2025. Sales rose 43.52% to Rs 4457.37 crore in the year ended March 2026 as against Rs 3105.75 crore during the previous year ended March 2025.

Powered by Capital Market - Live News